Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review
2021 ◽
pp. 1-13
Keyword(s):
Keyword(s):
2018 ◽
Vol 21
(6)
◽
pp. 577-586
◽
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e404-e405
2019 ◽
Vol 105
(1)
◽
pp. E511
◽
Keyword(s):
Keyword(s):
2016 ◽
Keyword(s):
Keyword(s):
2007 ◽
Vol 69
(3)
◽
pp. S503
Keyword(s):